In this issue of the JCI, Nagasaki and colleagues demonstrate a role for 15LO1 in controlling redox balance and epithelial homeostasis in T2-high asthma by metabolizing AA that is esterified to membrane phospholipids
A relatively new addition to the arsenal of antidiabetic compounds studied in relation to Type 2 Diabetes mellitus (T2DM) have been the incretin mimetics, a group of substances that appear to work on the glucagon-like peptide-1 (GLP-1) receptor and enhance insulin secretion from the pancreatic -cells in a glucose-dependent manner, possibly more potently in hyperglycemic conditions, while suppressing glucagon secretion at the same time
You can also contact Michelle Fulmer, Section Director, and she will have one of the lawyers contact you.Michelle can be reached using the contact form at the bottom of this page
Myth: Compounded semaglutide is an illegal or underground version of Wegovy
In the same month that Eli Lilly announced the staggering efficacy of Retatrutide, Novo Nordisk underwent a trial of "ice and fire" in its performance
Also Read: 5 Eye-Opening Things Science Got Wrong (And Right) about Ozempic Should I stop my GLP-1 medication if Im concerned about bone health
